IL139072A0 - Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine - Google Patents

Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine

Info

Publication number
IL139072A0
IL139072A0 IL13907299A IL13907299A IL139072A0 IL 139072 A0 IL139072 A0 IL 139072A0 IL 13907299 A IL13907299 A IL 13907299A IL 13907299 A IL13907299 A IL 13907299A IL 139072 A0 IL139072 A0 IL 139072A0
Authority
IL
Israel
Prior art keywords
acetylglucosamine
treatment
composition
inflammatory bowel
bowel disease
Prior art date
Application number
IL13907299A
Other languages
English (en)
Original Assignee
Glucogenics Pharmaceuticals In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glucogenics Pharmaceuticals In filed Critical Glucogenics Pharmaceuticals In
Priority claimed from PCT/CA1999/000218 external-priority patent/WO1999053929A1/en
Publication of IL139072A0 publication Critical patent/IL139072A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
IL13907299A 1998-04-17 1999-03-12 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine IL139072A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002234936A CA2234936C (en) 1998-04-17 1998-04-17 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
PCT/CA1999/000218 WO1999053929A1 (en) 1998-04-17 1999-03-12 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine

Publications (1)

Publication Number Publication Date
IL139072A0 true IL139072A0 (en) 2001-11-25

Family

ID=4162337

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13907299A IL139072A0 (en) 1998-04-17 1999-03-12 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine

Country Status (8)

Country Link
EP (1) EP1071432A1 (xx)
JP (1) JP2002512195A (xx)
CA (1) CA2234936C (xx)
CZ (1) CZ20003846A3 (xx)
HU (1) HUP0101514A3 (xx)
IL (1) IL139072A0 (xx)
NO (1) NO20005223L (xx)
PL (1) PL343634A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008103345A2 (en) 2007-02-19 2008-08-28 Marine Polymer Technologies, Inc. Hemostatic compositions and therapeutic regimens
KR101098581B1 (ko) * 2009-01-09 2011-12-26 서울대학교산학협력단 Ａｂｈ 항원을 이용한 염증질환 개선용 조성물
CN103108638B (zh) 2010-04-15 2016-11-09 海洋聚合物技术公司 聚-n-乙酰葡萄糖胺纳米纤维的抗菌应用
WO2012142581A1 (en) 2011-04-15 2012-10-18 Marine Polymer Technologies, Inc. Treatment of disease with poly-n-acety glucosamine nanofibers
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
WO2014142938A1 (en) * 2013-03-15 2014-09-18 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
HUE049247T2 (hu) * 2014-11-26 2020-09-28 Evonik Operations Gmbh Etanol hatásával szemben ellenálló gyógyászati vagy táplálék-gyógyszerészeti kompozíció
KR102104507B1 (ko) * 2019-08-23 2020-04-24 브릿지바이오테라퓨틱스(주) 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법

Also Published As

Publication number Publication date
HUP0101514A3 (en) 2003-07-28
NO20005223D0 (no) 2000-10-17
PL343634A1 (en) 2001-08-27
NO20005223L (no) 2000-11-20
EP1071432A1 (en) 2001-01-31
CZ20003846A3 (cs) 2002-03-13
HUP0101514A2 (hu) 2001-11-28
JP2002512195A (ja) 2002-04-23
CA2234936A1 (en) 1999-10-17
CA2234936C (en) 2004-06-29

Similar Documents

Publication Publication Date Title
IL132145A (en) Compositions for treating inflammatory bowel disease and uses thereof
EP1581119A4 (en) COMPOSITIONS AND METHODS FOR THERAPY AND DIAGNOSIS FOR INFLAMMATORY BOWEL DISEASE
EP1240136A4 (en) USE OF BIOLOGICALLY ACTIVE VITAMIN-D COMPOUNDS FOR THE PREVENTION AND TREATMENT OF INFLAMMABLE INTESTINAL DISEASES
HUP9900950A3 (en) Use of nicotine derivatives for producing pharmaceutical compositions suitable for treating inflammatory bowel disease
EP1578385A4 (en) COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF INFLAMMATORY INTESTINAL DISEASES
IL142929A0 (en) Local delivery of drugs to the colon for local treatment of colonic diseases
EP1129217A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING DISEASES
EP1119255A4 (en) NEW COMPOSITIONS AND METHOD FOR THE PREVENTION AND TREATMENT OF PROTOCOL DISEASES
AU2027595A (en) Pharmaceutical composition for treating inflammatory bowel diseases
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU6386499A (en) Method and composition for treatment of inflammatory bowel disease
AU2002246519A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
HUP0101514A3 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
EP1085906A4 (en) ANTIBODIES AGAINST CYTOKINS FOR THE PREVENTION AND TREATMENT OF INFLAMMABLE INTESTINAL DISEASES
IL147946A0 (en) Treatment of inflammatory or malignant disease using dnazymes
AU2001257406A1 (en) Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
HUP9900309A3 (en) Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases
EP1107778A4 (en) TREATMENT OF DISEASE CONDITIONS
AU4034800A (en) Novel compositions and methods for prevention and treatment of protozoal disease
HUP0000569A3 (en) Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
GB9725346D0 (en) Pharmaceutical composition for the treatment of inflammatory bowel disease
AU2001294999A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
GB9701041D0 (en) Treatment of inflammatory bowel conditions